Dudediligence.

Monte Rosa Therapeutics, Inc

GLUENASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Oct 18-KRegulation FD disclosure and other events7.018.019.01
  2. Sep 88-KRegulation FD disclosure and other events7.018.019.01
  3. Aug 1413GPassive stake of 5% or more (13G), filed by Vestal Point Capital
  4. Aug 610-QQuarterly report
  5. Aug 68-KResults of operations2.029.01
  6. Jun 118-KShareholder vote5.07
  7. May 710-QQuarterly report
  8. May 78-KResults of operations2.029.01
  9. Mar 1710-KAnnual report
  10. Mar 178-KResults of operations2.029.01
  11. Feb 108-KOfficer or director change5.02
  12. Jan 98-KMaterial agreement and other events1.018.019.01
  13. Jan 9424B5Prospectus for an offering
  14. Jan 78-KOther events8.019.01
  15. Jan 7424B5Prospectus for an offering
  16. Jan 78-KRegulation FD disclosure and other events7.018.019.01
  17. Dec 16, 20258-KRegulation FD disclosure and other events7.018.019.01
  18. Nov 6, 202510-QQuarterly report
  19. Nov 6, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  20. Sep 15, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  21. Aug 7, 202510-QQuarterly report
  22. Aug 7, 20258-KResults of operations2.029.01
  23. Jun 13, 20258-KShareholder vote5.07
  24. May 8, 202510-QQuarterly report
  25. May 8, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  26. Mar 20, 2025S-3Shelf registration
  27. Mar 20, 202510-KAnnual report
  28. Mar 20, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  29. Jan 10, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  30. Dec 13, 20248-KOfficer or director change5.02
  31. Dec 5, 20248-KRegulation FD disclosure and other events7.018.019.01
  32. Nov 7, 202410-QQuarterly report